Bios Fund I QP, LP

Insider profile

Bios Fund I QP, LP's trades of Lantern Pharma Inc.'s stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
402.74
Quantity 48,202
Value US$4,418,303
Transaction date
Proposed sale
Price
459.28
Quantity 28,276
Value US$1,700,157
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-05-27 2025-05-27 PrS Proposed sale
48,202
402.74
US$4,418,303
48,202 402.74 US$4,418,303
2024-04-26 2024-04-29 PrS Proposed sale
28,276
459.28
US$1,700,157
28,276 459.28 US$1,700,157